文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

纤维蛋白原激活PAK1/Cofilin信号通路保护内皮屏障完整性

Fibrinogen Activates PAK1/Cofilin Signaling Pathway to Protect Endothelial Barrier Integrity.
PubMed 文献 · Shock · 2021-01-01
一句话结论纤维蛋白原通过激活PAK1/cofilin通路减少应力纤维和内皮通透性,并在出血性休克小鼠中增加肺p-PAK1至接近假手术水平并显著防止肺漏出。

研究探讨纤维蛋白原保护内皮屏障的细胞内信号通路。体外实验将原代人肺微血管内皮细胞分别置于10%乳酸林格液或10%纤维蛋白原盐水溶液(5 mg/mL)中,纤维蛋白原处理增加syndecan-1、PAK1磷酸化、cofilin去磷酸化,减少应力纤维和通透性,且不影响肌球蛋白轻链磷酸化。PAK1沉默阻断纤维蛋白原诱导的cofilin去磷酸化和屏障保护。小鼠出血性休克后用乳酸林格液或纤维蛋白原复苏,纤维蛋白原使肺p-PAK1表达增至接近假手术水平并显著防止肺漏出。结论提示纤维蛋白原经PAK1/cofilin通路减少内皮通透性。

要点

  • 体外:原代人肺微血管内皮细胞经5 mg/mL纤维蛋白原盐水溶液处理较10%乳酸林格液增加syndecan-1、PAK1磷酸化和cofilin去磷酸化,并减少应力纤维和通透性。
  • PAK1沉默可阻断纤维蛋白原诱导的cofilin去磷酸化和屏障完整性保护,提示PAK1是该通路的关键节点。
  • 纤维蛋白原不影响肌球蛋白轻链磷酸化,提示其屏障保护不依赖该张力通路。
  • 小鼠出血性休克后复苏:纤维蛋白原较乳酸林格液使肺p-PAK1表达增至接近假手术水平,并显著防止肺血管漏出。
  • 作者结论:纤维蛋白原激活PAK1信号使cofilin去磷酸化,导致应力纤维解聚并降低内皮通透性。

适用人群与场景

  • 体外:原代人肺微血管内皮细胞。
  • 动物:出血性休克小鼠,复苏时分别给予乳酸林格液或纤维蛋白原。

研究设计与关键结果

  • 体外实验:纤维蛋白原盐水溶液(5 mg/mL)处理较10%乳酸林格液处理增加syndecan-1、PAK1活化(磷酸化)和cofilin活化(去磷酸化),并减少应力纤维和通透性。
  • 机制验证:沉默PAK1可阻止纤维蛋白原诱导的cofilin去磷酸化和屏障完整性保护;纤维蛋白原不影响肌球蛋白轻链活化(磷酸化)。
  • 小鼠出血性休克后复苏:纤维蛋白原较乳酸林格液使肺p-PAK1表达增至接近假手术水平,并显著防止肺血管漏出;出血性休克本身降低肺p-PAK1水平并导致显著肺血管漏出。

证据类型、等级与局限

  • 证据类型:体外原代人肺微血管内皮细胞实验与小鼠出血性休克复苏实验。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为纤维蛋白原通过激活PAK1信号使cofilin去磷酸化,导致应力纤维解聚并降低内皮通透性,为纤维蛋白原保护内皮屏障提供了新的机制解释。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: We recently demonstrated that fibrinogen stabilizes syndecan-1 on the endothelial cell (EC) surface and contributes to EC barrier protection, though the intracellular signaling pathway remains unclear. P21 (Rac1) activated kinase 1 (PAK1) is a protein kinase involved in intracellular signaling leading to actin cytoskeleton rearrangement and plays an important role in maintaining endothelial barrier integrity. We therefore hypothesized that fibrinogen binding to syndecan-1 activated the PAK1 pathway.

METHODS: Primary human lung microvascular endothelial cells were incubated in 10% lactated Ringers (LR) solution or 10% fibrinogen saline solution (5 mg/mL). Protein phosphorylation was determined by Western blot analysis and endothelial permeability measured by fluorescein isothiocyanate (FITC)-dextran. Cells were silenced by siRNA transfection. Protein concentration was measured in the lung lavages of mice.

RESULTS: Fibrinogen treatment resulted in increased syndecan-1, PAK1 activation (phosphorylation), cofilin activation (dephosphorylation), as well as decreased stress fibers and permeability when compared with LR treatment. Cofilin is an actin-binding protein that depolymerizes F-actin to decrease stress fiber formation. Notably, fibrinogen did not influence myosin light chain activation (phosphorylation), a mediator of EC tension. Silencing of PAK1 prevented fibrinogen-induced dephosphorylation of cofilin and barrier integrity. Moreover, to confirm the in vitro findings, mice underwent hemorrhagic shock and were resuscitated with either LR or fibrinogen. Hemorrhage shock decreased lung p-PAK1 levels and caused significant lung vascular leakage. However, fibrinogen administration increased p-PAK1 expression to near sham levels and remarkably prevented the lung leakage.

CONCLUSION: We have identified a novel pathway by which fibrinogen activates PAK1 signaling to stimulate/dephosphorylate cofilin, leading to disassembly of stress fibers and reduction of endothelial permeability.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wu F, Chipman A, Dong JF, et al. Fibrinogen Activates PAK1/Cofilin Signaling Pathway to Protect Endothelial Barrier Integrity. Shock. 2021. PMID: 32433215. doi:10.1097/SHK.0000000000001564

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。